Tech Company Financing Transactions
Leyden Labs Funding Round
On 3/25/2021, Leyden Labs raised $47 million in Series A investment from GV, Casdin Capital and F-Prime Capital.
Transaction Overview
Company Name
Announced On
3/25/2021
Transaction Type
Venture Equity
Amount
$47,000,000
Round
Series A
Investors
GV (Lead Investor) (David Schenkein)
Casdin Capital (Eli Casdin)
F-Prime Capital (Stephen Knight)
private investors (Brook Byers)
Proceeds Purpose
Series A financing will be used to develop the Leyden Labs' platform and portfolio of product candidates.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Keizersgracht 290 A
Amsterdam, 1016 EW
The Netherlands
Amsterdam, 1016 EW
The Netherlands
Phone
Undisclosed
Website
Email Address
Overview
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral families to protect humanity from known and future viruses.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Koenraad Wiedhaup
Chief Scientific Officer
Jaap Goudsmit
Controller
Lotte van Alst
VP - Bus. Development
Ronald Brus
VP - Bus. Development
Suha Jhaveri
VP - Bus. Development
Willemijn Kremer
VP - General Counsel
Albert Jan van Soelen
VP - Operations
Marieke van der Lans
VP - R & D
Galit Alter
Browse more venture capital transactions:
Prev: 3/25/2021: Incode venture capital transaction
Next: 3/25/2021: Rec Room venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs